↓ Skip to main content

Long-Term Cost-Effectiveness of Insulin Glargine Versus Neutral Protamine Hagedorn Insulin for Type 2 Diabetes in Thailand

Overview of attention for article published in Applied Health Economics and Health Policy, March 2016
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

policy
1 policy source
twitter
4 X users
facebook
1 Facebook page

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
111 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Long-Term Cost-Effectiveness of Insulin Glargine Versus Neutral Protamine Hagedorn Insulin for Type 2 Diabetes in Thailand
Published in
Applied Health Economics and Health Policy, March 2016
DOI 10.1007/s40258-016-0228-3
Pubmed ID
Authors

Unchalee Permsuwan, Nathorn Chaiyakunapruk, Piyameth Dilokthornsakul, Kednapa Thavorn, Surasak Saokaew

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 111 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 <1%
Unknown 110 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 18 16%
Student > Master 15 14%
Student > Ph. D. Student 13 12%
Student > Postgraduate 6 5%
Student > Bachelor 5 5%
Other 18 16%
Unknown 36 32%
Readers by discipline Count As %
Medicine and Dentistry 24 22%
Economics, Econometrics and Finance 12 11%
Nursing and Health Professions 11 10%
Pharmacology, Toxicology and Pharmaceutical Science 10 9%
Social Sciences 3 3%
Other 10 9%
Unknown 41 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 August 2020.
All research outputs
#5,897,596
of 22,854,458 outputs
Outputs from Applied Health Economics and Health Policy
#247
of 776 outputs
Outputs of similar age
#82,478
of 300,116 outputs
Outputs of similar age from Applied Health Economics and Health Policy
#7
of 25 outputs
Altmetric has tracked 22,854,458 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 776 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.9. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 300,116 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.